Position in GRFS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$113,265
+$21,453 QoQ
Shares Held
15,998
+39.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 164 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MML INVESTORS SERVICES, LLC holds $792,094,279 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
176,497 | $211,695,814 | |
| 2 | ABBV |
AbbVie Inc.
|
632,277 | $159,106,184 | |
| 3 | JNJ |
Johnson & Johnson
|
408,511 | $103,749,538 | |
| 4 | AMGN |
Amgen Inc
|
212,074 | $76,796,236 | |
| 5 | MRK |
Merck & Co., Inc.
|
444,129 | $57,070,576 | |
| 6 | NVS |
Novartis AG
|
255,770 | $40,084,274 | |
| 7 | PFE |
Pfizer Inc
|
1,393,942 | $33,566,123 | |
| 8 | AZN |
Astrazeneca PLC
|
171,254 | $32,473,183 |
All Filings in GRFS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,265 | 15,998 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $91,812 | 11,448 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $99,072 | 10,596 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $101,940 | 10,235 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||